Peer-Reviewed

2019

  • Seewald, N. J., Kidwell, K.M., Nahum-Shani, I., Wu, T., McKay, J.R., Almirall, D. "Sample size considerations for comparing dynamic treatment regimens in a sequential multiple-assignment randomized trial with a continuous longitudinal outcome," Statistical Methods in Medical Research. https://doi.org/10.1177/0962280219877520 ArXiv [stat.ME].
  • Seewald, N.J., Smith, S.N., Lee, A.J., Klasnja, P., Murphy, S.A. (2019), "Practical Considerations for Data Collection and Management in Mobile Health Micro-Randomized Trials". Statistics in Biosciences, 11:2, 355-370. https://doi.org/10.1007/s12561-018-09228-w

2018

  • Klasnja, P., Smith, S., Seewald, N.J., Lee, A., Hall, K., Luers, B., Hekler, E., Murphy, S.A. (2018), "Efficacy of contextually-tailored suggestions for physical activity: A micro-randomized trial of HeartSteps." Annals of Behavioral Medicine, 53:6, 573-582. https://doi.org/10.1093/abm/kay067
  • Kidwell, K.M., Seewald, N.J., Tran, Q., Kasari, K., Almirall, D. (2018), "Design and Analysis Considerations for Comparing Dynamic Treatment Regimens with Binary Outcomes from Sequential Multiple Assignment Randomized Trials" Journal of Applied Statistics, 45:9, 1628-1651. http://dx.doi.org/10.1080/02664763.2017.1386773

2017

  • Kadakia, K.C., Kidwell, K.M., Seewald, N.J., Snyder, C.F., Storniolo, A.M., Otte, J.L., Flockhart, D.A., Hayes, D.F., Stearns, V., Henry, N.L. (2017), "Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors" Breast Cancer Research and Treatment. Full Text.
  • Meurer, W. J., Seewald, N. J., Kidwell, K. M. (2017), "Sequential Multiple Assignment Randomized Trials: An Opportunity for Improved Design of Stroke Reperfusion Trials", Journal of Stroke and Cerebrovascular Diseases. 26:4, 717-724. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2016.09.010.

2016

  • Hertz, D.L., Kidwell, K.M., Seewald, N.J., Gersch, C. L., Desta, Z., Flockhart, D. A., ... Rae, J. M. (2016), "Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer," The Pharmacogenomics Journal. http://doi.org/10.1038/tpj.2016.60.
  • Kadakia, K. C., Snyder, C. F., Kidwell, K. M., Seewald, N. J., Flockhart, D. A., ... Henry, N. L. (2016), "Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer," The Oncologist. http://doi.org/10.1634/theoncologist.2015-0349.
  • Hertz, D. L., Caram, M. V., Kidwell, K. M., Thibert, J. N., Gersch, C., Seewald, N. J., ... Cooney, K. A. (2016), "Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines," Pharmacogenomics. http://doi.org/10.2217/pgs.15.162.

2013

  • Randolph, A. H., Seewald, N. J., Rickert, K. and Brown, S. N. (2013), "Tris (3, 5-di-tert-butylcatecholato) molybdenum (VI): Lewis Acidity and Nonclassical Oxygen Atom Transfer Reactions," Inorganic Chemistry. http://doi.org/10.1021/ic401736f.

2012

  • Marshall-Roth, T., Liebscher, S. C., Rickert, K., Seewald, N. J., Oliver, A. G. and Brown, S. N. (2012), "Nonclassical oxygen atom transfer reactions of oxomolybdenum(vi) bis(catecholate)," Chemical Communications. http://doi.org/10.1039/c2cc33523a

Book Chapters

  • Smith, S.N., Lee, A.J., Hall, K., Seewald, N.J., Boruvka, A., Murphy, S.A., Klasnja, P. "Design Lessons from a Micro-Randomized Pilot Study in Mobile Health." In Mobile Health, edited by J. Rehg, S.A. Murphy, and S. Kumar, 59-82. Cham: Springer, 2017.

Miscellaneous

  • Klasnja, P., Smith, S.N., Seewald, N.J., Lee, A.J., Hall, K., Murphy, S.A. (2017) "Effects of Contextually-Tailored Suggestions for Physical Activity: The HeartSteps Micro-Randomized Trial," Annals of Behavioral Medicine, 51, S902-S903.
  • Seewald, N. J., Sun, J., Liao, P. (2016) "MRT-SS Calculator: An R Shiny Application for Sample Size Calculation in Micro-Randomized Trials," arXiv:1609.00695 [stat.ME].
  • Hertz, D.L., Kidwell, K.M., Seewald, N.J., Gersch, C.L., Desta, Z., Flockhart, D.A., Storniolo, A.M., Stearns, V., Skaar, T.C., Hayes, D. F., Henry, N.L., and Rae, J.M. (2016), "Abstract P5-12-05: CYP3A4* 22 polymorphism is associated with increased exemestane concentrations in postmenopausal breast cancer patients," Cancer Research, 76, 4 [supplement], P5-12. http://dx.doi.org/10.1158/1538-7445.SABCS15-P5-12-05.
  • Kadakia, K.C., Kidwell, K.M., Seewald, N.J., Snyder, C.F., Flockhart, D.A., Otte, J.L., Hayes, D.F., Storniolo, A.M., Stearns, V., and Henry, N.L. (2016), "Crossover from One Aromatase Inhibitor (AI) to Another in the Exemestane and Letrozole Pharmacogenetics (ELPh) Trial," Journal of Clinical Oncology, 34, 3 [supplement], 158.
  • Mammoser, A.G., Weathers, S.S., Seewald, N.J., Taylor, J.M. and Junck, L. (2015), "Primary CNS lymphoma; a review of the University of Michigan experience 2004-2013," Journal of Clinical Oncology, 33, 15[supplement] e13012.
  • Kadakia, K. C., Snyder, C. F., Kidwell, K. M.,Seewald, N. J., Storniolo, A. M., ... Henry, N. L. (2015), "Associations between treatment-emergent symptoms and early discontinuation of aromatase inhibitor (AI) therapy," ASCO Meeting Abstracts Online, 33, e20745.